No, all herpes viruses are not the same. Eight distinct herpesviruses infect humans, and while they share a few core traits, they cause wildly different diseases, spread through different routes, and hide in different parts of your body. The virus behind a cold sore is not the same as the one that causes chickenpox, mono, or certain cancers.
What All Herpesviruses Have in Common
Every human herpesvirus is a large, double-stranded DNA virus wrapped in a protective envelope. They all share one defining behavior: once you’re infected, the virus never fully leaves your body. Instead, it goes dormant in specific cells and can reactivate later, sometimes causing symptoms again and sometimes not. This lifelong persistence is the hallmark of the entire herpesvirus family.
Beyond that shared blueprint, the eight viruses diverge considerably. Scientists sort them into three subfamilies based on how they behave in the body: alpha, beta, and gamma herpesviruses. Each subfamily targets different cell types, reproduces at different speeds, and causes a distinct set of problems.
The Eight Human Herpesviruses
Alpha Herpesviruses: HSV-1, HSV-2, and VZV
The alpha group includes herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2), and varicella-zoster virus (VZV). These viruses replicate quickly, infect a wide range of cell types, and go dormant in nerve cells. That’s why outbreaks follow nerve pathways: cold sores reappear in the same spot on the lip, shingles rashes follow a band along one side of the body.
HSV-1 spreads mainly through oral contact, saliva, and skin-to-skin touching around the mouth. It’s the classic cold sore virus. HSV-2 spreads through sexual contact and primarily causes genital herpes, with painful blisters or open sores around the genitals or anus. The two aren’t interchangeable, though. HSV-1 can cause genital infections through oral-genital contact, and the global numbers reflect this overlap: roughly 520 million people aged 15 to 49 had genital HSV-2 in 2020, while another 376 million had genital HSV-1 infections.
VZV is the virus behind chickenpox in children. After that initial infection clears, VZV hides in nerve cells near the spine and can reactivate decades later as shingles, a painful blistering rash. Unlike HSV-1 and HSV-2, VZV spreads through respiratory droplets and is highly contagious through the air.
Beta Herpesviruses: CMV, HHV-6, and HHV-7
Cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), and human herpesvirus 7 (HHV-7) make up the beta group. These viruses reproduce slowly and have a narrower range of cells they can infect. Most people pick them up during childhood without ever knowing it.
CMV is remarkably common and usually causes no symptoms in healthy adults. It becomes dangerous in two situations: when a pregnant person passes it to the fetus (causing congenital CMV, which can lead to hearing loss and developmental problems) and when someone with a weakened immune system, such as an organ transplant recipient, experiences reactivation. In those patients, CMV can attack the eyes, lungs, liver, or colon.
HHV-6 is best known as the cause of roseola, the fever-and-rash illness that affects nearly all children before age two. HHV-7 is closely related and also widespread in childhood, though it rarely causes recognizable disease on its own. Both viruses go dormant in immune cells rather than nerve cells.
Gamma Herpesviruses: EBV and HHV-8
Epstein-Barr virus (EBV) and human herpesvirus 8 (HHV-8, also called Kaposi sarcoma-associated herpesvirus) have the narrowest host range of the three groups, targeting specific immune cells called lymphocytes. These are the two herpesviruses linked to cancer.
EBV infects B cells and is the cause of mononucleosis (“mono”), the prolonged fatigue-and-sore-throat illness common in teenagers and young adults. Most people carry EBV by adulthood. In rare cases, the virus contributes to several cancers, including Burkitt lymphoma, Hodgkin lymphoma, nasopharyngeal carcinoma, and certain stomach cancers. Recent research has also linked EBV to an increased risk of multiple sclerosis.
HHV-8 doesn’t cause an obvious acute illness in most people. Its significance lies in its role in Kaposi sarcoma, a cancer of blood vessel linings that primarily affects people with HIV or other immune-suppressing conditions. HHV-8 is also connected to primary effusion lymphoma and some forms of Castleman disease.
Where Each Virus Hides During Latency
One of the clearest differences between herpesvirus types is where they set up camp for life. The alpha viruses (HSV-1, HSV-2, VZV) go dormant in neurons along sensory nerve pathways. This is why reactivation produces localized skin symptoms: the virus travels back down the nerve to the skin surface it originally infected.
The gamma viruses (EBV and HHV-8) are lymphotropic, meaning they settle into lymphocytes, a type of white blood cell. EBV specifically persists in memory B cells. This immune-cell tropism helps explain why these viruses are the ones associated with blood cancers and lymphomas. The beta viruses have more variable hiding spots, including certain immune cells and bone marrow progenitor cells.
Serious Complications Vary by Type
In healthy people, most herpesvirus infections cause mild illness or none at all. The serious complications differ dramatically depending on which virus is involved. HSV-1 can, in rare cases, cause encephalitis, a life-threatening brain inflammation. HSV-2 poses a particular danger to newborns: neonatal herpes typically develops in the first four weeks of life and can cause severe neurological damage or death.
For people with weakened immune systems, nearly all herpesviruses become more dangerous. CMV can cause retinitis (which threatens vision), pneumonia, and colitis. HHV-6 can cause encephalitis. HSV infections can become disseminated, spreading beyond the skin to internal organs. People living with HIV face especially aggressive herpesvirus complications, including persistent esophageal ulcers, colitis, and meningitis.
Treatment and Vaccination Differences
The antiviral drugs used to treat herpesvirus infections all work by blocking the virus’s ability to copy its DNA, but different drugs are matched to different viruses. Acyclovir (and its oral form, valacyclovir) is the standard treatment for HSV and VZV infections. Ganciclovir and its oral version are the primary treatments for CMV. Letermovir, a newer drug with a completely different mechanism, is used specifically to prevent CMV reactivation in transplant patients.
These medications control outbreaks and reduce viral activity, but none of them eliminate the virus from the body. Because the virus sits dormant inside cells where antivirals can’t reach it, treatment manages the infection rather than curing it.
Vaccination exists for only one human herpesvirus so far: VZV. The chickenpox vaccine dramatically reduced varicella cases, and a newer shingles vaccine helps prevent reactivation in older adults. Efforts to develop an HSV vaccine have been ongoing for decades but have not yet succeeded. No vaccines exist for CMV, EBV, HHV-6, HHV-7, or HHV-8.
How Transmission Differs Across Types
The eight viruses spread in fundamentally different ways. HSV-1 passes through oral contact, kissing, and shared utensils. HSV-2 is sexually transmitted. VZV is airborne, spreading through respiratory droplets and the fluid from chickenpox blisters. CMV transmits through bodily fluids including saliva, urine, breast milk, and blood. EBV spreads primarily through saliva, which is why mono is sometimes called “the kissing disease.” HHV-6 and HHV-7 spread through saliva in early childhood, which is why nearly everyone is infected before school age. HHV-8 transmission varies by region but includes saliva and sexual contact.
This diversity in transmission routes is one of the reasons herpesviruses are so successful as a group. Collectively, they’ve found a way to reach nearly every human on the planet through a range of everyday and intimate contacts, then persist for a lifetime. But despite sharing that strategy, each of the eight is a distinct virus with its own biology, its own risks, and its own clinical significance.